Clarification of Reporting of Conflicts of Interest

In the Original Investigation entitled “Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial”¹ published in the October 15, 2019, issue of JAMA, potential conflicts of interest were inadvertently omitted for 2 authors. Dr Graves’ disclosure should have read: “Dr Graves reported that he is an employee of Berry Consultants; Berry Consultants was compensated by Ferring Pharmaceuticals for clinical design work.” Dr Lewis’ disclosure should have read: “Dr Lewis reported that he is an employee of Berry Consultants; Berry Consultants was compensated by Ferring Pharmaceuticals for clinical design work.” This article has been corrected online.